- Home
- DARE vs MOBX Comparison
DARE vs MOBX Comparison
Compare DARE & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DARE
- MOBX
- Stock Information
- Founded
- DARE N/A
- MOBX 2020
- Country
- DARE United States
- MOBX United States
- Employees
- DARE N/A
- MOBX N/A
- Industry
- DARE Biotechnology: Pharmaceutical Preparations
- MOBX
- Sector
- DARE Health Care
- MOBX
- Exchange
- DARE Nasdaq
- MOBX Nasdaq
- Market Cap
- DARE 31.9M
- MOBX 29.9M
- IPO Year
- DARE N/A
- MOBX N/A
- Fundamental
- Price
- DARE $3.21
- MOBX $0.61
- Analyst Decision
- DARE Strong Buy
- MOBX
- Analyst Count
- DARE 4
- MOBX 0
- Target Price
- DARE $20.33
- MOBX N/A
- AVG Volume (30 Days)
- DARE 64.6K
- MOBX 113.9K
- Earning Date
- DARE 11-14-2024
- MOBX 11-29-2024
- Dividend Yield
- DARE N/A
- MOBX N/A
- EPS Growth
- DARE N/A
- MOBX N/A
- EPS
- DARE N/A
- MOBX N/A
- Revenue
- DARE $1,881,316.00
- MOBX $3,921,000.00
- Revenue This Year
- DARE $388.48
- MOBX N/A
- Revenue Next Year
- DARE $67.37
- MOBX N/A
- P/E Ratio
- DARE N/A
- MOBX N/A
- Revenue Growth
- DARE 88.13
- MOBX 214.69
- 52 Week Low
- DARE $3.05
- MOBX $0.55
- 52 Week High
- DARE $7.56
- MOBX $12.50
- Technical
- Relative Strength Index (RSI)
- DARE 36.32
- MOBX 40.30
- Support Level
- DARE $3.42
- MOBX $0.62
- Resistance Level
- DARE $4.60
- MOBX $0.74
- Average True Range (ATR)
- DARE 0.32
- MOBX 0.07
- MACD
- DARE -0.09
- MOBX 0.01
- Stochastic Oscillator
- DARE 2.11
- MOBX 52.21
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.
About MOBX Mobix Labs Inc.
Mobix Labs Inc is a fabless semiconductor company developing disruptive next generation wireless and connected solutions that are designed to cater to a broad range of applications in markets including 5G infrastructure, satellite communications, automotive, consumer electronics, e-mobility, healthcare, infrastructure and defense.